Rahul Pannala

TL;DR: The success of a strategy using new-onset hyperglycaemia and diabetes as a screening tool to identify people with a high likelihood of having asymptomatic pancreatic cancer will depend largely on the ability to differentiate pancreatic-cancer-associated diabetes from the more common type-2 diabetes by use of a (serological) biomarker.

TL;DR: PaC is a powerful diabetogenic state; DM associated with PaC is often new-onset, resolves following cancer resection, and appears to be associated with conventional risk factors for DM.

TL;DR: Patients with type 1 AIP have a high relapse rate, but patients with type 2 AIP do not experience relapse, and AIP does not affect long-term survival.

TL;DR: The ASGE Technology Committee endorses using these advanced imaging modalities to guide targeted biopsies for the detection of dysplasia during surveillance of patients with previously nondysplastic BE, thereby replacing the currently used random biopsy protocols.

TL;DR: EMR has become an established therapeutic option for premalignant and early-stage GI malignancies, particularly in the esophagus and colon, and can aid in the diagnosis and therapy of subepithelial lesions localized to the muscularis mucosa or submucosa.